Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.613
-0.028 (-4.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lyell Immunopharma Analyst Ratings
Total Analysts
2
Consensus Rating
Sell
Price Target
$1.00
Upside
+63.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Nov 12, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $6 → $1 | Strong Buy → Sell | Downgrades | $6 → $1 | +63.21% | Oct 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Oct 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +63.21% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +879.27% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $6 → $1 | Strong Buy → Hold | Downgrades | $6 → $1 | +63.21% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +879.27% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +879.27% | Feb 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +1,205.70% | Nov 9, 2023 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $15 → $5 | Buy → Hold | Downgrades | $15 → $5 | +716.06% | Aug 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,368.91% | May 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +1,368.91% | Mar 2, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | +552.85% | Jan 24, 2023 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $15 → $7 | Buy → Hold | Downgrades | $15 → $7 | +1,042.48% | Nov 14, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 11, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +1,858.54% | Oct 17, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.